Increased adenosine A 2A receptors in the brain of Parkinson’s disease patients with dyskinesias

By Calon Frédéric  

Brain, Vol. 127, Iss. 5, 2004-05 ,pp. : 1075-1084

Oxford University Press

Access to resources Recommend Favorite

Parkinson's disease: PET studies, neural stem cells and an adenosine receptor antagonist

By Strupp Michael  

Journal of Neurology, Vol. 255, Iss. 4, 2008-04 ,pp. : 616-618

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Adenosine Receptor Antagonists on the In Vivo LPS-Induced Inflammation Model of Parkinson's Disease

By Gołembiowska Krystyna  

Neurotoxicity Research, Vol. 24, Iss. 1, 2013-07 ,pp. : 29-40

Springer Publishing Company

Access to resources Recommend Favorite

Dopamine receptor agonists in the therapy of Parkinson’s disease

By Foley P.   Gerlach M.   Double K. L.   Riederer P.  

Journal of Neural Transmission, Vol. 111, Iss. 10-11, 2004-10 ,pp. : 1375-1446

Springer Publishing Company

Access to resources Recommend Favorite

Melatonin in Parkinson's disease

By Medeiros C.  

Journal of Neurology, Vol. 255, Iss. 5, 2008-05 ,pp. : 759-759

Springer Publishing Company

Access to resources Recommend Favorite